[시장보고서]세계의 근적외선 이미징 시장 : 제품별, 수술별, 용도별, 최종 사용자별, 지역별 예측(-2030년)

세계의 근적외선 이미징 시장 : 제품별, 수술별, 용도별, 최종 사용자별, 지역별 예측(-2030년)

Near-infrared Imaging Market by Product (Imaging System, Probe, Dye), Procedure, Application, End User & Region - Global Forecast to 2030

상품코드 : 1807078 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2025년 08월

페이지 정보 : 영문 289 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,159,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,617,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,787,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,463,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 근적외선 이미징 시장 규모는 2025년 12억 8,000만 달러에서 2030년까지 19억 9,000만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR 9.3%의 성장이 예상됩니다.

조사 범위
조사 대상 연도	2024-2030년
기준 연도	2024년
예측 기간	2025-2030년
단위	10억 달러
부문	제품, 수술, 용도, 최종 사용자, 지역
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

수술 가이던스와 분자 이미징에 대한 하이브리드 근적외선 이미징 모달리티의 채용과 근적외선 이미징 모달리티 기술의 진보, 세계적인 수술 건수 증가가 예측 연간 시장 성장을 밀어올릴 것으로 예측되는 주요 요인입니다. 게다가, 기존의 시각화 기법에 대한 근적외선 이미징의 이점은 근적외선 이미징 수요 증가에 크게 기여하는 요인이 되었습니다.

수술별로는 소화기 수술 부문이 2024년에 가장 큰 시장 점유율을 차지했습니다.

대장암, 크론병, 궤양성 대장염, 위종양 등 소화기 질환의 이환율 상승이 수술적 개입의 필요성을 현저히 높여 조사 기간의 컬럼 수요를 촉진할 것으로 예측됩니다.

용도별로는 임상 이미징 부문이 2024년 최대 시장 점유율을 차지했습니다.

이 부문의 성장은 이 기술이 제공하는 이점과 임상 응용을 위한 형광 이미징의 진보로 이 이미징 양식의 채택 증가로 인한 것으로 예측됩니다.

아시아태평양이 예측기간에 가장 높은 성장률을 기록할 전망입니다.

많은 환자의 존재, 노인 증가, 암과 심혈관 질환의 거대한 인구 기반이 예측 기간의이 지역의 성장을 가속합니다.

이 보고서는 세계의 근적외선 이미징 시장에 대한 조사 분석을 통해 주요 촉진요인과 억제요인, 경쟁 구도, 미래 동향 등의 정보를 제공합니다.

소개
시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 과제
규제 분석
- 규제기관, 정부기관, 기타 조직
- 규제 상황
상환 분석
밸류체인 분석
- 연구개발
- 조달 및 제품 개발
- 마케팅, 판매, 유통
공급망 분석
- 저명 기업
- 중소기업
- 최종 사용자
생태계 분석
Porter's Five Forces 분석
주요 이해관계자와 구매 기준
무역 분석
- 근적외선 이미징 제품의 수입 데이터(HS 코드 902750)
- 근적외선 이미징 제품의 수출 데이터(HS 코드 902750)
특허 분석
가격 설정 분석
- 근적외선 이미징 제품의 평균 판매 가격 : 유형별
- 근적외선 이미징 제품의 평균 판매 가격 : 주요 기업별
- 근적외선 이미징 제품의 평균 판매 가격 : 지역별
기술 분석
- 주요 기술
- 보완 기술
- 인접 기술
사례 연구 분석
- 기술적인 과제
- 계약 제조에 대한 의존도 저하
주요 컨퍼런스 및 이벤트(2025-2026년)
고객사업에 영향을 주는 동향/혼란
투자 및 자금조달 시나리오
미충족 요구의 분석
근적외선 이미징 시장에서의 생성형 AI의 영향
근적외선 이미징 시장에 대한 2025년 미국 관세의 영향
- 주요 관세율
- 가격의 영향 분석
- 국가/지역에 대한 가격의 영향
- 국가/지역에 미치는 영향
- 최종 이용 산업에 미치는 영향

제6장 근적외선 이미징 시장 : 제품별

소개
디바이스
- 형광 이미징 시스템
- 형광 및 생물 발광 이미징 시스템
약품 및 프로브
- 인도시아닌 그린
- 기타 시약
염료
- 유기 염료
- 나노입자 염료

제7장 근적외선 이미징 시장 : 수술별

소개
암 수술
- 뇌종양 수술
- 기타 암 수술
소화기 수술
- 대장 수술
- 기타 소화기 수술
심혈관 수술
성형외과 및 재건 수술
산부인과 수술
기타 수술

제8장 근적외선 이미징 시장 : 용도별

소개
전임상 이미징
임상 이미징
의료 이미지

제9장 근적외선 이미징 시장 : 최종 사용자별

소개
병원 및 외과 클리닉
제약 및 바이오테크놀러지 기업
연구소 및 학술 기관
기타 최종 사용자

제10장 근적외선 이미징 시장 : 지역별

소개
북미
- 북미의 거시경제 전망
- 미국
- 캐나다
유럽
- 유럽의 거시 경제 전망
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 아시아태평양의 거시 경제 전망
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
라틴아메리카
- 라틴아메리카의 거시 경제 전망
- 브라질
- 멕시코
- 기타 라틴아메리카
중동 및 아프리카
- 중동 및 아프리카의 거시 경제 전망
- GCC 국가
- 기타 중동 및 아프리카

제11장 경쟁 구도

개요
주요 진입기업의 전략 및 강점
수익 분석(2020-2024년)
시장 점유율 분석(2024년)
기업 평가 매트릭스 : 주요 기업(2024년)
기업 평가 매트릭스 : 스타트업 및 중소기업(2024년)
기업 평가 및 재무 지표
브랜드 및 제품 비교
경쟁 시나리오

제12장 기업 프로파일

주요 기업
- STRYKER
- CARL ZEISS MEDITEC AG
- PERKINELMER, INC.
- OLYMPUS CORPORATION
- LEICA MICROSYSTEMS
- KARL STORZ SE & CO. KG
- SHIMADZU CORPORATION
- LI-COR BIOTECH, LLC
- HAMAMATSU PHOTONICS KK
- QUEST MEDICAL IMAGING BV
- MERCK KGAA(SIGMA-ALDRICH)
- MIZUHO MEDICAL CO., LTD.
- TELEDYNE PRINCETON INSTRUMENTS
- THERMO FISHER SCIENTIFIC INC.
- FLUOPTICS SAS(PART OF GETINGE)
- MEDTRONIC
- CAYMAN CHEMICAL
- MP BIOMEDICALS
- CRYSTA-LYN CHEMICAL COMPANY
- GOWERLABS LTD.
기타 기업
- NIRX MEDICAL TECHNOLOGIES, LLC
- EXOSENS(XENICS NV)
- BIOTIUM
- TOKYO CHEMICAL INDUSTRY(INDIA) PVT. LTD.
- AAT BIOQUEST, INC.
- OXFORD INSTRUMENTS
- MOTHERSON
- PHOTON ETC
- SOTERIX MEDICAL INC.
- KERNEL

제13장 부록

JHS

영문 목차

영문목차

The global near IR imaging market is projected to reach USD 1.99 billion by 2030 from USD 1.28 billion in 2025, at a CAGR of 9.3% during the forecast period.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Product, Procedure, Application, End User, and Region
Regions covered	North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

The adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging, technological advancements in near-infrared imaging modalities, and the increasing number of surgical procedures globally are major factors anticipated to boost market growth in the forecasting years. Additionally, the advantages of near-infrared imaging over conventional visualization methods also pose as a factor that contributes enormously to the increase in demand for near-infrared imaging.

By procedure, the gastrointestinal surgeries segment accounted for the largest share of the market in 2024.

Based on procedure, the near-infrared imaging market is segmented into gastrointestinal surgeries, plastic/reconstructive surgeries, cancer surgeries, obstetrics & gynecology surgeries, cardiovascular surgeries, and other procedures. The gastrointestinal surgeries segment is further segmented into colorectal surgeries and other gastrointestinal surgeries. The rising incidence of gastrointestinal diseases such as colorectal cancer, Crohn's disease, ulcerative colitis, and gastric tumors significantly increases the need for surgical interventions, which is expected to fuel the demand for columns in the studied period.

By application, the clinical imaging segment accounted for the largest market share in 2024.

By application, the market is segmented into medical imaging, preclinical imaging, and clinical imaging. The clinical imaging segment accounted for the largest share of the market in 2024. The growth of this segment can be attributed to the increasing adoption of this imaging modality owing to the advantages offered by this technique and advancements in fluorescence imaging for clinical applications.

The Asia Pacific region is expected to register the highest growth rate during the forecast period.

By region, the near-infrared imaging market covers North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is estimated to register the highest growth rate during the forecast period. The presence of a large patient population, a rising geriatric population, and a huge population base for cancer and cardiovascular disease will fuel growth in this region during the forecast period.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1- 48%, Tier 2- 36%, and Tier 3- 16%
By Designation: Directors- 14%, C-level- 10%, and Others- 76%
By Region: North America- 40%, Europe- 32%, Asia Pacific- 20%, Latin America- 5%, Middle East & Africa- 3%

The prominent players in the near infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US), LI-COR Biotech (US), Hamamatsu Photonics K.K. (Japan), Quest Medical Imaging B.V. (Netherlands), Merck KGaA (Germany), MIZUHO Corporation (Japan), Teledyne Princeton Instruments (US), Thermo Fisher Scientific Inc. (US), FLUOPTICS SAS (Getinge, France), Medtronic (Ireland), Cayman Chemical (US), MP Biomedicals (US), Crysta-LYN Chemical Company (US), and Gowerlabs Ltd. (UK), among others.

Research Coverage

This report studies the near-infrared imaging market based on product, procedure, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights on the following pointers:

Analysis of key drivers (Increasing number of surgical procedures globally, advantages of near-infrared imaging over conventional visualization methods, technological advancements in near-infrared imaging modalities, adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging), restraints (Lengthy approval process for near-infrared fluorophores, high initial capital and operational costs of near-infrared systems, availability of alternate technologies), opportunities (Growth potential in emerging economies, use of blockchain for distribution and storage of medical images), and challenges (Hospital budget cuts, dearth of trained professionals in emerging economies) influencing the growth of the near infrared imaging market
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the near-infrared imaging market
Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the near-infrared imaging market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the near-infrared imaging market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA SOURCES
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 List of secondary sources
- 2.1.2 PRIMARY DATA SOURCES
  - 2.1.2.1 List of key primary stakeholders interviewed
  - 2.1.2.2 Insights from primary experts
2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
- 2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
2.3 MARKET FORECASTING
2.4 PRIMARY RESEARCH VALIDATION
2.5 DATA TRIANGULATION & MARKET BREAKDOWN
2.6 RESEARCH ASSUMPTIONS
- 2.6.1 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW
4.2 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT AND COUNTRY (2024)
4.3 NEAR-INFRARED IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 NEAR-INFRARED IMAGING MARKET: REGIONAL MIX, 2023-2030 (USD MILLION)

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing number of surgical procedures globally
  - 5.2.1.2 Advantages of near-infrared imaging over conventional visualization methods
  - 5.2.1.3 Technological advancements in near-infrared imaging modalities
  - 5.2.1.4 Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Lengthy approval process of near-infrared fluorophores
  - 5.2.2.2 High initial capital and operational costs of near-infrared systems
  - 5.2.2.3 Availability of alternate technologies
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Growth potential for major players in emerging economies
  - 5.2.3.2 Use of blockchain for distribution and storage of medical images
- 5.2.4 CHALLENGES
  - 5.2.4.1 Hospital budget cuts
  - 5.2.4.2 Dearth of trained professionals in emerging economies
5.3 REGULATORY ANALYSIS
- 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.3.2 REGULATORY LANDSCAPE
  - 5.3.2.1 North America
    - 5.3.2.1.1 US
    - 5.3.2.1.2 Canada
  - 5.3.2.2 Europe
  - 5.3.2.3 Asia Pacific
    - 5.3.2.3.1 Japan
    - 5.3.2.3.2 China
    - 5.3.2.3.3 India
  - 5.3.2.4 Middle East (GCC Region)
    - 5.3.2.4.1 UAE
    - 5.3.2.4.2 Saudi Arabia
  - 5.3.2.5 Africa
5.4 REIMBURSEMENT ANALYSIS
5.5 VALUE CHAIN ANALYSIS
- 5.5.1 RESEARCH & DEVELOPMENT
- 5.5.2 PROCUREMENT & PRODUCT DEVELOPMENT
- 5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.6 SUPPLY CHAIN ANALYSIS
- 5.6.1 PROMINENT COMPANIES
- 5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
- 5.6.3 END USERS
5.7 ECOSYSTEM ANALYSIS
5.8 PORTER'S FIVE FORCES ANALYSIS
- 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.8.2 BARGAINING POWER OF SUPPLIERS
- 5.8.3 BARGAINING POWER OF BUYERS
- 5.8.4 THREAT OF SUBSTITUTES
- 5.8.5 THREAT OF NEW ENTRANTS
5.9 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.9.2 KEY BUYING CRITERIA
5.10 TRADE ANALYSIS
- 5.10.1 IMPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750)
- 5.10.2 EXPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750)
5.11 PATENT ANALYSIS
5.12 PRICING ANALYSIS
- 5.12.1 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY TYPE
- 5.12.2 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY KEY PLAYER
- 5.12.3 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY REGION
5.13 TECHNOLOGY ANALYSIS
- 5.13.1 KEY TECHNOLOGIES
  - 5.13.1.1 InGaAs (Indium Gallium Arsenide) detectors
  - 5.13.1.2 CMOS sensors
  - 5.13.1.3 Hyperspectral imaging
- 5.13.2 COMPLEMENTARY TECHNOLOGIES
  - 5.13.2.1 Image processing software
  - 5.13.2.2 Optical coherence tomography (OCT)
  - 5.13.2.3 Raman spectroscopy
- 5.13.3 ADJACENT TECHNOLOGIES
  - 5.13.3.1 SWIR (short-wave infrared) imaging
  - 5.13.3.2 Thermal imaging
  - 5.13.3.3 UV-VIS-NIR spectroscopy
5.14 CASE STUDY ANALYSIS
- 5.14.1 TECHNOLOGICAL CHALLENGES
- 5.14.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING
5.15 KEY CONFERENCES & EVENTS, 2025-2026
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.17 INVESTMENT & FUNDING SCENARIO
5.18 UNMET NEEDS ANALYSIS
5.19 IMPACT OF GENERATIVE AI ON NEAR-INFRARED IMAGING MARKET
5.20 IMPACT OF 2025 US TARIFFS ON NEAR-INFRARED IMAGING MARKET
- 5.20.1 KEY TARIFF RATES
- 5.20.2 PRICE IMPACT ANALYSIS
- 5.20.3 PRICE IMPACT ON COUNTRY/REGION
  - 5.20.3.1 US
  - 5.20.3.2 Europe
  - 5.20.3.3 Asia Pacific
- 5.20.4 IMPACT ON COUNTRY/REGION
  - 5.20.4.1 US
  - 5.20.4.2 Europe
  - 5.20.4.3 Asia Pacific
- 5.20.5 IMPACT ON END-USE INDUSTRIES

6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 DEVICES
- 6.2.1 FLUORESCENCE IMAGING SYSTEMS
  - 6.2.1.1 Higher sensitivity and better real-time image guidance during surgeries to drive market
- 6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS
  - 6.2.2.1 Better sensitivity and higher efficiency at lower costs to drive market
6.3 AGENTS/PROBES
- 6.3.1 INDOCYANINE GREEN
  - 6.3.1.1 Increasing utilization of small organic probes in near-infrared imaging to drive segmental growth
- 6.3.2 OTHER REAGENTS
6.4 DYES
- 6.4.1 ORGANIC DYES
  - 6.4.1.1 Unique molecular structure and better compatibility with biological systems to support market growth
- 6.4.2 NANOPARTICLE DYES
  - 6.4.2.1 Better brightness and enhanced signal intensity compared to organic dyes to boost adoption

7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE

7.1 INTRODUCTION
7.2 CANCER SURGERIES
- 7.2.1 BRAIN CANCER/TUMOR SURGERIES
  - 7.2.1.1 Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market growth
- 7.2.2 OTHER CANCER SURGERIES
7.3 GASTROINTESTINAL SURGERIES
- 7.3.1 COLORECTAL SURGERIES
  - 7.3.1.1 Advancements in treatment strategies and procedures to support market growth
- 7.3.2 OTHER GASTROINTESTINAL SURGERIES
7.4 CARDIOVASCULAR SURGERIES
- 7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET GROWTH
7.5 PLASTIC/RECONSTRUCTIVE SURGERIES
- 7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO BOOST MARKET
7.6 OBSTETRICS & GYNECOLOGY SURGERIES
- 7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO CONTRIBUTE TO GROWTH
7.7 OTHER PROCEDURES

8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 PRECLINICAL IMAGING
- 8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET
8.3 CLINICAL IMAGING
- 8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO FUEL GROWTH
8.4 MEDICAL IMAGING
- 8.4.1 GROWING APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET

9 NEAR-INFRARED IMAGING MARKET, BY END USER

9.1 INTRODUCTION
9.2 HOSPITALS & SURGICAL CLINICS
- 9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET GROWTH
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO BOOST GROWTH
9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
- 9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH
9.5 OTHER END USERS

10 NEAR-INFRARED IMAGING MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
  - 10.2.2.1 Advanced healthcare infrastructure and favorable regulations to drive market
- 10.2.3 CANADA
  - 10.2.3.1 Increased availability of research funding to drive market
10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
  - 10.3.2.1 Increasing healthcare expenditure and government spending to drive market growth
- 10.3.3 FRANCE
  - 10.3.3.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to boost market
- 10.3.4 UK
  - 10.3.4.1 Growing government initiatives and increasing incidence of chronic diseases to support growth
- 10.3.5 ITALY
  - 10.3.5.1 Increased availability of reimbursement coverage for diagnostic procedures to fuel growth
- 10.3.6 SPAIN
  - 10.3.6.1 Increasing prevalence of cancer and growing private-public funding to propel growth
- 10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
  - 10.4.2.1 Increasing healthcare reforms and government investments to drive market
- 10.4.3 JAPAN
  - 10.4.3.1 Fast adoption of advanced technologies and growth in geriatric population to boost market
- 10.4.4 INDIA
  - 10.4.4.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market
- 10.4.5 AUSTRALIA
  - 10.4.5.1 Growing healthcare spending and increasing investments in research to fuel growth
- 10.4.6 SOUTH KOREA
  - 10.4.6.1 Presence of advanced healthcare system and increased awareness about diseases to contribute to growth
- 10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
  - 10.5.2.1 Greater purchasing power and more favorable demographic conditions to boost growth
- 10.5.3 MEXICO
  - 10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
  - 10.6.2.1 Supportive government initiatives to aid market growth
- 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET
11.3 REVENUE ANALYSIS, 2020-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 11.5.5.1 Company footprint
  - 11.5.5.2 Region footprint
  - 11.5.5.3 Product footprint
  - 11.5.5.4 Procedure footprint
  - 11.5.5.5 Application footprint
  - 11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 11.6.5.1 Detailed list of key startups/SMEs
  - 11.6.5.2 Competitive benchmarking of key emerging players/startups
11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES
- 11.9.2 DEALS
- 11.9.3 EXPANSIONS

12 COMPANY PROFILES

12.1 KEY PLAYERS
- 12.1.1 STRYKER
  - 12.1.1.1 Business overview
  - 12.1.1.2 Products offered
  - 12.1.1.3 Recent developments
    - 12.1.1.3.1 Product launches
    - 12.1.1.3.2 Deals
  - 12.1.1.4 MnM view
    - 12.1.1.4.1 Right to win
    - 12.1.1.4.2 Strategic choices
    - 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 CARL ZEISS MEDITEC AG
  - 12.1.2.1 Business overview
  - 12.1.2.2 Products offered
  - 12.1.2.3 Recent developments
    - 12.1.2.3.1 Product launches
    - 12.1.2.3.2 Deals
    - 12.1.2.3.3 Expansions
  - 12.1.2.4 MnM view
    - 12.1.2.4.1 Right to win
    - 12.1.2.4.2 Strategic choices
    - 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 PERKINELMER, INC.
  - 12.1.3.1 Business overview
  - 12.1.3.2 Products offered
  - 12.1.3.3 Recent developments
    - 12.1.3.3.1 Expansions
- 12.1.4 OLYMPUS CORPORATION
  - 12.1.4.1 Business overview
  - 12.1.4.2 Products offered
  - 12.1.4.3 Recent developments
    - 12.1.4.3.1 Product launches
    - 12.1.4.3.2 Deals
    - 12.1.4.3.3 Expansions
  - 12.1.4.4 MnM view
    - 12.1.4.4.1 Right to win
    - 12.1.4.4.2 Strategic choices
    - 12.1.4.4.3 Weaknesses & competitive threats
- 12.1.5 LEICA MICROSYSTEMS
  - 12.1.5.1 Business overview
  - 12.1.5.2 Products offered
  - 12.1.5.3 Recent developments
    - 12.1.5.3.1 Deals
    - 12.1.5.3.2 Expansions
  - 12.1.5.4 MnM view
    - 12.1.5.4.1 Right to win
    - 12.1.5.4.2 Strategic choices
    - 12.1.5.4.3 Weaknesses & competitive threats
- 12.1.6 KARL STORZ SE & CO. KG
  - 12.1.6.1 Business overview
  - 12.1.6.2 Products offered
  - 12.1.6.3 MnM view
    - 12.1.6.3.1 Right to win
    - 12.1.6.3.2 Strategic choices
    - 12.1.6.3.3 Weaknesses & competitive threats
- 12.1.7 SHIMADZU CORPORATION
  - 12.1.7.1 Business overview
  - 12.1.7.2 Products offered
  - 12.1.7.3 Recent developments
    - 12.1.7.3.1 Product launches
    - 12.1.7.3.2 Deals
    - 12.1.7.3.3 Expansions
- 12.1.8 LI-COR BIOTECH, LLC
  - 12.1.8.1 Business overview
  - 12.1.8.2 Products offered
  - 12.1.8.3 Recent developments
    - 12.1.8.3.1 Product launches
- 12.1.9 HAMAMATSU PHOTONICS K.K.
  - 12.1.9.1 Business overview
  - 12.1.9.2 Products offered
  - 12.1.9.3 Recent developments
    - 12.1.9.3.1 Expansions
- 12.1.10 QUEST MEDICAL IMAGING B.V.
  - 12.1.10.1 Business overview
  - 12.1.10.2 Products offered
- 12.1.11 MERCK KGAA (SIGMA-ALDRICH)
  - 12.1.11.1 Business overview
  - 12.1.11.2 Products offered
  - 12.1.11.3 Recent developments
    - 12.1.11.3.1 Expansions
- 12.1.12 MIZUHO MEDICAL CO., LTD.
  - 12.1.12.1 Business overview
  - 12.1.12.2 Products offered
- 12.1.13 TELEDYNE PRINCETON INSTRUMENTS
  - 12.1.13.1 Business overview
  - 12.1.13.2 Products offered
- 12.1.14 THERMO FISHER SCIENTIFIC INC.
  - 12.1.14.1 Business overview
  - 12.1.14.2 Products offered
- 12.1.15 FLUOPTICS SAS (PART OF GETINGE)
  - 12.1.15.1 Business overview
  - 12.1.15.2 Products offered
- 12.1.16 MEDTRONIC
  - 12.1.16.1 Business overview
  - 12.1.16.2 Products offered
- 12.1.17 CAYMAN CHEMICAL
  - 12.1.17.1 Business overview
  - 12.1.17.2 Products offered
- 12.1.18 MP BIOMEDICALS
  - 12.1.18.1 Business overview
  - 12.1.18.2 Products offered
- 12.1.19 CRYSTA-LYN CHEMICAL COMPANY
  - 12.1.19.1 Business overview
  - 12.1.19.2 Products offered
- 12.1.20 GOWERLABS LTD.
  - 12.1.20.1 Business overview
  - 12.1.20.2 Products offered
12.2 OTHER PLAYERS
- 12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC
- 12.2.2 EXOSENS (XENICS NV)
- 12.2.3 BIOTIUM
- 12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.
- 12.2.5 AAT BIOQUEST, INC.
- 12.2.6 OXFORD INSTRUMENTS
- 12.2.7 MOTHERSON
- 12.2.8 PHOTON ETC
- 12.2.9 SOTERIX MEDICAL INC.
- 12.2.10 KERNEL

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS